title: Simultaneous determination of desloratadine and montelukast sodium using second-derivative synchronous fluorescence spectrometry enhanced by an organized medium with applications to tablets and human plasma.
abstract: A rapid, simple, and sensitive second-derivative synchronous fluorimetric method has been developed and validated for the simultaneous analysis of a binary mixture of desloratadine (DSL) and montelukast sodium (MKT) in their co-formulated tablets. The method is based on measurement of the synchronous fluorescence intensities of the two drugs in McIlvaine's buffer, pH 2.3, in the presence of carboxy methyl cellulose sodium (CMC) as a fluorescence enhancer at a constant wavelength difference (Δλ) of 160 nm. The presence of CMC enhanced the synchronous fluorescence intensity of DSL by 216% and that of MKT by 28%. A linear dependence of the concentration on the amplitude of the second derivative synchronous fluorescence spectra was achieved over the ranges of 0.10-2.00 and 0.20-2.00 µg/mL with limits of detection of 0.02 and 0.03, and limits of quantification of 0.05 and 0.10 µg/mL for DSL and MKT, respectively. The proposed method was successfully applied for the determination of the studied compounds in laboratory-prepared mixtures and tablets. The results were in good agreement with those obtained with the comparison method. The high sensitivity attained by the proposed method allowed the determination of MKT in spiked human plasma with average % recovery of 100.11 ± 2.44 (n = 3).
authors.affiliation: Department of Analytical Chemistry, Mansoura University, 35516, Mansoura, Egypt.
authors.forename: F A
authors.initials: FA
authors.lastname: Ibrahim
authors.forename: N
authors.initials: N
authors.lastname: El-Enany
authors.forename: R N
authors.initials: RN
authors.lastname: El-Shaheny
authors.forename: I E
authors.initials: IE
authors.lastname: Mikhail
mesh_terms: D000085:Acetates / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood; D002138:Calibration; D002266:Carboxymethylcellulose Sodium / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods; D003521:Cyclopropanes; D006801:Humans; D006863:Hydrogen-Ion Concentration; D057230:Limit of Detection; D017336:Loratadine / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood; D011804:Quinolines / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012997:Solvents / Q000737:chemistry; D013050:Spectrometry, Fluorescence / Q000379:methods*; D013440:Sulfides; D013607:Tablets / Q000032:analysis
chemical_list: D000085:Acetates; D003521:Cyclopropanes; D011804:Quinolines; D012997:Solvents; D013440:Sulfides; D013607:Tablets; D017336:Loratadine; C121345:desloratadine; D002266:Carboxymethylcellulose Sodium; C093875:montelukast
keywords: desloratadine; montelukast sodium; organized medium; pharmaceutical preparations; plasma; second-derivative synchronous fluorescence